AGT and hypertensive disorder: In addition, inhibition of miR-140-5p attenuated the hypertension and vascular smooth muscle dysfunction in Ang II-treated mice in vivo, suggesting that miR-140-5p is a potential target for treatment of vascular dysfunction.